2. GROWTH : Bottomline in the healthcare economy
DISCIPLINE : Rationally Navigated
THE MAGAZINE FOR THE PHARMA LEADERS
PHARMACEUTICAL
LEADERSHIP
AWARDS 2011
Honouring Excellence in Healthcare & Pharmaceuticals
2011 Gen-Next Indian Pharma Leaders
&
- Re-Inventing Drivers for Growth -
Saturday,10th December,2011,
Hotel Lalit, Intercontinental, Mumbai, India
- The Future Belongs to those who are Fast -
Leadership is Made! Not Born!!
The future cannot help you unless you are willing to listen
through the confusion. You cannot learn from the future if you are
overwhelmed by the present or stuck in the past.The Republic of
India faces a number of pressing challenges in health and health
care. By 2020, if left unresolved, these challenges will not only
lead to increased health insecurity but also to dramatic
COLLAPSE : We were not Prepared
TRANSFORMATION : Foundation of Health Resiliency

3. 1
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Driver's For Growth -
Chairman's Message
A
T
s we embark a full thoughtful analysis of Generation Next Pharma Leaders at Industry's most eagerly awaited
Annual meet 4th Annual Pharmaceutical Leadership Summit & Awards 2011 to be staged by Pharmaleaders in
association with Indo-American Chamber of Commerce ( IACC) on Saturday,10th December 2011 at Hotel Lalit
Intercontinental( Near Mumbai Airport), Mumbai , India, welcome to the brand new world of Generation Next Indian
Pharma Leaders who have risen under the shadow of their visionary fathers & has been instrumental in shaping up the
healthcare industry what it is today. A careful analysis of the present leadership transition & succession will reveal that
indeed, Indian pharmaceutical industry has been heading for a metamorphosis due to the induction of new way of thinking by
the Generation Next Pharmaceutical Pharma Leaders. The evolution of Indian pharmaceutical Sector since independence
has been the story of great show of resilience displayed by the patriarchs who dominated Indian pharma sector in reverese
engineering & operated under the domain of License Raj till the enunciation of economic liberalization in 1991 under the
visionary Finance Minister Manmohan Singh, currently PM. India was exposed to globalization & was thrown plethora of
challenges & opportunities.
he first three to four decade of the evolution of Indian Pharma sector saw the visionary legends who scripted the
growth story & brought milestone achievements against the powerful MNC's who continued their move to grab the
market share with their high Research-base product range. Late Dr Parvinder Singh of Ranbaxy, Dr Yusuf
Hameid of Cipla, I A Modi & Raman Bhai Patel of erstwhile Cadila group, Samprada Singh of Alkem, Suresh Kare of
Indoco, Habil Khorakiwala of Wockhardt are some of the notable names that fought against all odds & built-up rapidly
their respective empires. While many of the erstwhile regime has changed or diminished or renovated, the new emerging
power-equations have come in to fuel the growth engine. “I can say with all confidence & beyond any shadow of doubt that
these Pharma Leaders not only mapped the unorganized pharma market but got adapted to the emerging marketing
scenario as they changed their Type-Writer to modern day Laptop.While doing so, they went extra miles in Joint Ventures,
Acquisitions & Research outlook, leaving a rich legacy to their successors, only time can say that the rich leadership style
they practiced in bringing reforms to their own systems, how their sons, daughters & professional designated board will
be able to accelerate the pace”. Born with silver spoon in their mouth, these billionaire entrepreneurs featured in this story
also the others who due to lack of space or unavailability of authentic source of informations have taken the center stage of
their growth engine, so far, are struggling with ideas & remain deeply under the shadow & influence of their fathers, as the
change from past style to present regime where technological innovations have dominated the space with great speed.
Undoubtedly, the foremost fathers of these firms have grown tremendously although we are hearing of class of thoughts &
differences of opinions as the companies which was running with one leadership & command has seen the two power-centers
& the loyalty of interests has shifted two-fold as the employees try their best to please both father-son duo. While the old
school of thought led by the founder clearly have the edge in decision making process but their shadows clearly reflect in the
power struggle.
Glimpses of
2
Satya Brahma
Chairman & Editor-In-Chief
Indian Affairs & Pharmaleaders Group

4. 3
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Driver's For Growth -
GENERATION NEXT INDIA PHARMA LEADERS
Moving beyond the healthcare debate : The Transformative Trends
Pharma's Value Proposition - How The Industry Must Change. Perspectives On Current Industry Challenges With Reference To
Pfizer's Strategy”, Mr. Sunil Madhok, Director, Business Development, Pfizer India Ltd
4
PROGRAMME
PROGRAM AGENDA : Saturday, 10th December, 2011
09:00 – 10:10 AM Registration & Refreshments
Opening Address – Mr. Satya Brahma, Editor-In-Chief, Pharma Leaders. Release of an exclusive
white paper on Booming Pharma Industry – The Road Ahead 2015.
10:00-10:15 AM
Welcome Address : Dr Lalit S Kanodia,President Indo-American Chamber of Commerce (IACC),
Western Region, & CMD, Datamatics Ltd.
10:15-10:30 AM
Inaugural Address : Shri Mahesh Zagade, IAS, commissioner of food and drug
administration (FDA) and food safety, Maharashtra.
10:30-11.00 AM
11.00-11.30 AM
Dr Shailesh Iyenger, MD, Aventis Pharma Ltd.
Keynote Address: Mr.Hasit Joshipura - MD, GSK India Ltd. Leadership Challenge for
the Gen-Next Indian Pharma Leaders. Lessons from the past, optimism for the future
1130-12.00PM
12.00-12.30 PM
12.30 -01.00 PM
12.00 -12.30 PM Keynote : The Gen-Next Indian Pharma Leaders : Leadership tips & Strategies.
Mr Ajit Singh, Chairman, ACG Worldwide.
12.30 -01.00 PM
01.00-02.00 PM Networking & Luncheon at Exhibition Hall
PROGRAMME
K e y n o t e A d d r e s s : R e b r a n d i n g P h a rma L e a d e r s h i p : Wh a t ' s t h e k e y t o s u c c e s s f o r
the next generation of Pharma leaders? How Pharma can change its image from a leading rand expert. What does it take to shake off
the negative connotations and be seen as a “star” industry again?. The key to success for the next generation of Pharma leaders will be
to harness and focus institutional brilliance by becoming more disciplined, transparent and agile. Our experience with Pharmas is
that they are loaded with forward thinking, technically brilliant, fast- and hard-working professionals. I've seen great strides in the
development of organizational structures and processes designed to shift focus and resources from one priority to another. The
challenge: That level of discipline currently resides at the top of most organizations. I believe there's a need for a much more
systemic, top-to-bottom, bottom-to-top approach built around agile development principles. The current environment may well be
the driver for that next level of alignment and focus.
Keynote Address : Dr. Rashmi Barbhaiya , CEO and Managing Director - Advinus Therapeutics Ltd. From Scientist To CEO. The
vision: Create a Pharmaceutical company focused on discovering and developing the next generation of high end commercialized
medicines. The best places to start? Recruiting next-generation leadership. In order to be successful, start-up biotechnology
andPharmaceutical companies need CEOs who are generalists, combining the necessary blend of business acumen, scientific
understanding, and communication skills.
Keynote: India : An Emerging Pharmaceutical Powerhouse : Dr Ajit V Dangi, Board Chairman, Fulford India Ltd. President &
CEO, Danseen Consulting .An Emerging Pharmaceutical Powerhouse. The presentation will cover Key strategic drivers for
profitable growth. Including enabling business environment, leveraging Intellectual property as a competitive strategy, building
international brands , inorganic growth thru` mergers , acquisitions and alliances, changing paradigm in Pharmaceutical R&D,
Biosimilar and OTC Opportunities , making India a Destination of Choice in CRAMS by moving from cost arbitrage to intellectual
a r b i t r a g e a n d c a p i t a l i z i n g o n h e a l t h c a r e r e f o r m s i n t h e d e v e l o p e d w o r l d .
Challenges & Oppourtunities of Nutraceutical Markets in India. Mr V.S.Reddy, CMD, British Biologicals Nutraceutical market is set to
achieve a market size of Rs 90 billion in 2013 at a CAGR of 20.24%. Nutraceuticals are gaining acceptance globally for their ability to
address several diseases. Vitamins, Minerals and Nutrients constitute about 85% of the global market whileantioxidants and anti-agents
account for 10% other segments such as herbal extracts occupy 5% of the market. The US has been the major market for nutraceuticals
with India and China becoming fastest growing markets.
02.00 - 02.30 PM
Emergence of Biotech Entrepreneurs: Leadership role in 2010 : New Business Models for Breakthrough Growth : The Next-
Generation Pharmaceutical Value Chain. Dr Krishna Ella, CMD, Bharat Biotech International Ltd.
02:30-03:00 PM
03:00-03.30 PM
The case for personalised medicine – is this the future and, if so, how will we pay for it?
Dr. Chandr a shekha r Po tka r, Di r e c t o r, Medi c a l and Re gul a t o r y Af f a i r s , Pf i z e r Indi a Ltd .
It is becoming clear that targeting particular treatments to smaller patient populations is more effective than a “one-size-fits-all”
approach. But is there an upside for drug manufacturers? Are there benefits which will outweigh the potential increase in marketing and
R&D costs? This panel will look at new developments in personalised medicine and discuss whether it can be made to pay its way.
D i f f e r e n t i a t e o r D i e - P h a r m a c e u t i c a l I n d u s t r y i n I n d i a .
The Pharma industry is awash with talk about the inevitable doom facing the medical rep. They speak of the medical rep as some
outdated, outmoded, non-thinking, inflexible, creature. A modern-day Dodo that cannot adjust to the changing environment around it.
The Pharma business environment, like any other business environment, has evolved over recent years. Most Pharma companies had
not fully anticipated the scale of this evolution and have found themselves reacting to change rather than leading it.Faced with reduced
access to their prescriber customers the Pharma industry's reaction was not to try and understand why access was falling and address the
root cause, but rather, to create additional trading faces to give them more opportunities for access. In the UK, the blame was laid at the
door of change in the political environment. GPs were now too busy with GP fundholding - their administrative load had increased - and
therefore they had less time to see reps. They were forced to have a minimum number of patients on their list so they had to amalgamate
into group practices - spec calls had declined and long-term appointment systems were making access more difficult. Mr.Deepak Naik,
M a n a g i n g D i r e c t o r H e a l t h ' N ' U T h e r a p e u t i c s P v t . L t d .
03.30-04.00 PM Networking Refreshments Break at the Exhibition Hall.
04.00-04.30 PM M r A n a n d D e s a i , N a t i o n a l P r e s i d e n t , I A C C & M a n a g i n g P a r t n e r , D S K L e g a l .
Do Pharmaceutical Companies Have Debt Crisis Strategy?. A Legal Perspective. The Obama Administration's proposed fiscal budget
for 2012 suggested that all bets are off for biopharmaceutical revenue safeguards, but it never had a chance with Congress, as evidenced
by a unanimous no-thank-you from the Senate in late May. But that was before debt ceiling talks and the alleged possibility of a default
emerged as the driver of the fiscal solvency debate.
04:30-05:00 PM Are FDI & Price Control Policy in Indian Pharma Sector deterrent for growth & Globalize Indian Healthcare
Industry.Dr.Kannan Vishwanath, Vice – Chairman & MD , Aanjaneya Lifecare Ltd
05:00-05:30 PM
05:30-06:00 PM
Mr Shailendra Singh, Joint Managing Director, Percept Limited .
The Art of Making a
Blockbuster Brand – Reviving DEAD to LIVE
Narayan Gad, CEO, Formulations, Panacea Biotech Ltd.
. Different stakeholders in the value chain, including healthcare providers, patient groups and
That Will REALLY Define Our Future.
governments, will discuss the changing demands on the industry and how they can be reconciled with Pharma's commercial interests.
Issues for discussion will include: How can Pharma re-establish trust with patients, investors and diverse stakeholders? What do
different players in the healthcare system value, and how can the industry meet their needs? How can partnering enable the Pharma
industry to find new revenue streams? How does the Pharma business model need to change to capture value in new ways?
06.00 –06.30 PM
06:30-07:00 PM
Networking & Refreshments in Exhibition Hall
07.00 –07.30 PM PANELDISCUSSION: Generation Next Indian Pharma Leaders : Billioner Minds
Reinventing drivers for growth.
1.Satya Brahma, Editor-In-Chief, Pharmaleaders
2.Mr Daara Patel, Secretary General, IDMA
3.Mr Narayan Gad, CEO- Formulations, Panacea Biotech Ltd
4.Mr. Subodh Priolkar, President, IPA, President Colourcon Asia
5.Dr. Ajit. V. Dangi, President, Danseen Consulting
6.Mr Dinesh Mody, Director, JBCPL Ltd.
7.Dr.Kannan Vishwanath, Vice - Chairman 7 MD , Aanjaneya Lifecare Ltd.
Address by Chief Guest Shri Pranab Mukherjee, Finance Minister, Government of India. & 4th Annual
Pharmaceutical Leadership Awards 2011 presented by Finance Minister
08.00- 09.00 PM
090.00PM Cocktail & Dinner with Entertainment Gala Celebration Night
Onwards
- Reinventing Driver's For Growth -
Summit Moderated By Mr S. Krishnakumar, Head, Future Steps

5. 5
- Reinventing Driver's For Growth -
6
SPEAKERS
Mr. S. Krishnakumar : Head – Future Step
Future Step's
Mr. Satya Brahma, Editor-In-Chief, Pharma Leaders.
SPEAKERS
Krishnakumar is currently the Head of various initiatives to embrace & empower the diverse sectors with new age
talent management. Prior to this, he enjoyed memorable innings with reputed Companies such as FDC, Alkem, Warnbury etc & was
responsible for image building exercise & strategic acquisitions & leadership position in corporate decision making.
Satya Brahma is currently the Chairman of Network 7 Media group which has interest in media, publishing & events.
Over 12 years of Rich Experience in Journalism & Mass Communication out of which major parts of the career in
revising the framework of communications in India's Leading Corporate Houses & World's Largest NGO. Organized
& showcased some of India's biggest leadership events & his ability to stay unafraid is his biggest asset whilehe feels
that our life becomes meaningless the day when we lose hopes & ignore practical realities.
Dr. Lalit. S. Kanodia :
Dr. Lalit S. Kanodia, the founder and Chairman of Datamatics Group of Companies is one of the pioneers in the Indian
Software and Offshore Services Industry. He founded Datamatics in 1975, prior to which he was instrumental in setting up
of Tata Consultancy Services in 1967. Dr. Kanodia is an Executive Member of NASSCOM, the apex body of the IT-BPO
industry in India. He has also been designated as the Honorary Consul General of Chile in India by the Government of
Chile. In the past, he has held several eminent positions with various industry associations, which include- President of the
Management Consultant's Association of India and Chairman (Western Region) of the Electronics & Computer Software.
Dr. Kanodia has also been on the Board of Directors of several large conglomerates.
Mr. Mahesh Zagade :
Zagade Is The Commissioner Of Food And Drug Administration (FDA) And Food Safety, Maharashtra. He serves as an Indian
Administrative Services ( IAS) & was in the past Head of various prestigious institutions of the Government.
Dr. Shailesh Ayyangar :
Dr. Shailesh Ayyangar is the Vice-President of OPPI & Managing Director, India & Vice President, South Asia, Aventis Pharma Ltd.,
(Group Sanofi Aventis). Dr. Ayyangar is a topper is the Post Graduate Programme in Business Management from the Indian Institute
of Management, Ahmedabad (IIMA). He started his career with Ranbaxy and then moved on to Eskayef Ltd. (SmithKline Beecham)
and later became the Vice President – Sales Operations for Pharmaceuticals for SmithKline Beecham. Later on, Dr. Ayyangar was
selected to direct the International Tropical Medicine Initiative of SmithKline Beecham in U.K. He returned to India in 2000 to
oversee the merger of SmithKline Beecham commercial operations with GlaxoWellcome and subsequent to the merger he took over
as Executive Vice President, Sales and Marketing in GlaxoSmithKline in India. In 2002, he left GSK to take over as Managing
Director of Sanofi-Synthelabo operations in India.
Dr. Rashmi Barbhaiya :
Currently is CEO & MD of Advinus Therapeutics is an internationally reputed Pharma executive having extensive global experience
in handling diverse aspects of drug discovery and development. He has held several prestigious positions in leading pharmaceutical
companies and brings along an impeccable history in R&D operations and a successful background in business development and
deal making. Past offices held by Dr. Barbhaiya include President of Research and Development, Ranbaxy Research Laboratories,
New Delhi, India and Vice President in the Pharmaceutical Research Institute, Bristol-Meyers Squibb. In his 21 years with BMS and
about 2 years with Ranbaxy, Dr. Barbhaiya has been instrumental in discovery and development of numerous new drugs and drug
delivery products. Over his career, Dr. Barbhaiya has authored numerous publications (about 150) covering a broad range of
therapeutic areas. He obtained his PhD degree in Clinical Pharmacology from the St. Bartholomew's Hospital Medical College,
University of London and combined his education through post-doctoral training at the University of Florida and University of
Wisconsin.
Dr. Ajit Dangi
Is President and CEO of Danssen Consulting , a consultancy firm specialising in Pharmaceuticals , Life Sciences and
Healthcare . He is also Chairman of the Board of Fulford India Ltd. a subsidiary of Merck & Co. Inc. , USA . Dr. Dangi
has served as Director General of Organisation of Pharmaceutical Producers of India ( OPPI ) , a premier Association of
Research based International Pharmaceutical Companies for over seven years, where he played a key role in bringing IPR
regime in India . He is former President & Executive Director of Johnson & Johnson Ltd., India where he served for 20
years in various capacities. Dr. Dangi also worked with Unilever Group Co. in U.K. for five years before returning to India.
Mr. Ajit Singh,
Chairman of Associated Capsules Group of Companies, Mumbai and Executive Committee Member of the Federation of
Indian Chambers of Commerce and Industry, is also the founder official of the South Asian Pharmaceutical Excepients
Council. A veteran entrepreneur, Singh is a well-known figure in the Indian pharmaceutical industry and is also actively
involved with various organizations, which work on issues affecting the pharmaceutical industry. He is a member of the
Scientific Committee of the Indian Herbal Pharmacoepia 2003 and also the Advisor to the US Pharmacoepia for India.
Mr. V.S.Reddy
Is the Founder Charman of British Biologicals.India's Forefront science based industry, the pharmaceutical industry, was
further catapulted with the founding of British Biologicals in 1988. The visionary genius Mr. V.S. Reddy, the founder, gave
a new thrust and direction in the field of Nutraceuticals and emerged, British Biologicals as an innovative and pioneering
Nutraceutical company.ban. Fondly called "the protein people", British Biologicals is in the forefront offering Nutritional
supplement in nutritionally beneficial and condition based specialties like General Nutrition, Diabetes, Pregnancy and
Lactation, Respiratory Disorders, Menopause and Hepatic dysfunctions. Perfection is a way of life at British Biologicals.
The organization has grown from a small beginning in 1988, to become a Nutraceutical company of international repute
for reliability.
Dr. Krishna Ella
Ella is the CMD of Bharat Biotech International . Dr Ella pursued his early education in India and acquired his Postgraduate
Degree in Agricultural Sciences with Distinction and Gold Medals. After working with Sandoz (I) Ltd and Bayer, he
moved to the US for Higher Studies on a Rotary Foundation Scholarship. As a scientist par international standard, well
versed in the Plant/Human/Yeast systems, Dr. Ella has more than 30 scientific publications to his credit in peer reviewed
academic journals. His expertise in Gene Expression Systems has been well acclaimed and demonstrated, internationally.
He is a member of various high level Commissions.
Dr. Chandrashekhar Potkar
Management and clinical research background with MD in Pharmacology from University of Mumbai, MBA from Deakin
University, Australia and thereafter his MS, Clinical Research Administration from the George Washington University,
USA. He is one of the founder governing council members and faculty at Academy for clinical Excellence, the training
center for clinical research at Mumbai in collaboration with Bombay College of Pharmacy and Suven. Dr. Potkar is also
the founder member of Indian Society for Clinical Research, the professional society for clinical research professionals in
India. He is a life member of Indian Psychiatry Society and Indian Pharmacology Society.
Mr. Deepak Naik
Is the Managing Director of Health 'N' U Therapeutics Pvt. Ltd. Prior to setting up his own venture, Deepak held various
important positions in reputed companies such as Wockhardt, Ranbaxy etc. His last assignment was with Eisai
Pharmaceuticals India as Managing Director.
GENERATION NEXT INDIA PHARMA LEADERS
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Drivers For Growth -

6. 7
GENERATION NEXT INDIA PHARMA LEADERS
8
SPEAKERS SPEAKERS
PANELDISCUSSION: 08.00 - 09.00 PM
Generation Next Indian Pharma Leaders : Billionaire Minds, Reinventing
Drivers For Growth.
Mr. Satya Brahma, Editor-In-Chief, Pharmaleaders(Moderator)
Mr. Daara Patel, Secretary General, IDMA
Mr Narayan Gad, CEO- Formulations, Panacea Biotech Ltd
Mr. Subodh Priolkar, President, IPA, President Colourcon Asia
Dr. Ajit. V. Dangi, President, Danseen Consulting
Mr Dinesh Mody, Director, JBCPL Ltd.
Dr.Kannan Vishwanath, Vice - Chairman & MD, Aanjaneya Lifecare Ltd.
Mr. Anand Desai
Is the Managing Partner of reputed Legal firm DSK Legal. He also is the National President of Indo-American Chamber
of Commerce ( IACC). Anand has extensive specialist experience in the fields of banking laws, financial services,
M&A, intellectual property rights, media and entertainment, real estate, and outsourcing issues. Anand advises
various large corporates, funds and high networth individuals on diverse issues and has experience in advising the
s h i p p i n g a n d a v i a t i o n i n d u s t r y .
Mr. Shailendra Singh
Is the Joint Managing Director of Percept Limited, India's largest and only entertainment, media and communications
conglomerate. An undying spirit, inexhaustible ideas, a fastidious attitude and a great eye for detail are what define
the man, Shailendra Singh. His energy is rooted towards conceptualizing, planning and strategizing ways and means
to creating innovative content that works. His expertise and contribution over the past two decades to the arena of
Advertising, Sports, Talent, Movies and 360-degree communications are unparalleled, and truly make him the fastest
innovator and creator in the entertainment, media and communications domain in India.
Mr.Narayan Gad
is currently the CEO- Formulations of Indian Pharma Major Panacea Biotech Ltd. Prior to this assignment, Gad had a
successful tenure in reputed companies such as Dr reddy's Labs, Wockhard, Nicholas Piramal etc. Gad is a visiting
faculty to various Management Institutes & is a much sought after speaker on Management.
Mr. Sunil Madhok
is currently the Director Business Devlopment with Pharma MNC Pfizer Ltd. Sunil has an illustrious career with a
successful track record.Sunil has been instrumental in success story of Pfizer India & is responsible for the business
devlopment in india.
Dr.Kannan Vishwanath
Is Promoter & Managing Director Aanjaneya Lifecare Limited . Innovative and results driven leader focused on achieving
exceptional results in highly competitive environments that demand continuous improvement. Experience in driving
product, process and customer service improvement while building partnerships with key business decision makers.
Consistently increased production, reduced operating costs and improved product quality by utilizing world class
manufacturing concepts ( lean manufacturing six sigma, theory of constraints etc ) to optimise & rationalize
manufacturing processes and supply chain networks Known for building and motivating cross functional teams that
exceed corporate expectations. Prior to this, Kannan was with BENZOCHEM LIFESCIENCES PVT LTD & was Was
responsible for a Team of 50 people with $ 10 million budget including supply chain functions two sites, distribution
network all inclusive from product conception, procurement, planning through quality and operations to customer
delivery
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Driver's For Growth - - ReInventing Drivers For Growth -

7. NOMINATIONS NOMINATIONS
Business Leader of the Year 2011
1. Dr Habil F Khorakiwala, Chairman, Wockhardt Ltd (Vote HFK to+ 91 9892108169)
2. Mr. Glenn Saldanha, Chairman & MD (Vote GS to+ 91 9892108169)
3. Kewal Handa, Managing Director, Pfizer & Merck Ltd. (Vote KH to+ 91 9892108169)
Business Woman of the Year 2011 ( Gen-Next Pharma Leader)
1. Mrs Vinita Gupta, Lupin LTD (Vote VG to+ 91 9892108169)
2. Mrs Aditi Kare Panandikar, Director, Indoco Remedies Ltd (Vote AK to+ 91 9892108169)
3. Ms. Nandini Piramal, Executive Director, Piramal Healthcare Limited, (Vote NP to+ 91 9892108169)
4. Dr Manu Chaudhary, JMD, Venus Remedies Ltd. (Vote MC to+ 91 9892108169)
Dynamic Entreprenuer of the Year 2011
1. Dr. GSK Velu, Founder, Trivitron Group of Companies (Vote GV to+ 91 9892108169)
2. Mr K Raghavendra Rao, Chairman & Managing Director,Orchid (Vote KR to+ 91 9892108169)
3. Dhirendra Kumar, Managing Director,Camson Biotechnologies Ltd,(Vote DK to+ 91 9892108169)
4. Dr Krishna Ella, CMD, Bharat Biotech International Ltd ( Vote KE to ++ 91 9892108169)
Pharma OTC Company of the Year 2011
1. Alkem Health Foods (Vote AH to+ 91 9892108169)
2. Elder Pharmaceuticals Ltd (Vote EP to+ 91 9892108169)
3. Abbott Nutrition (Vote AN to+ 91 9892108169)
4. Ranbaxy Ltd ( Vote RAN to – 91 9892108169)
India's Most Admired Nutrition & Neutraceuticals of the Year 2011
1. Apex Laboratories Ltd (Vote APEX to+ 91 9892108169)
2. Abbott Nutrition (Vote AB to+ 91 9892108169)
3. British Biological (Vote BB to+ 91 9892108169)
4. Novartis India Ltd. (Vote NI to+ 91 9892108169)
Company of the Year 2011
1. Twilight Litaka Pharma Ltd. (Vote TL to+ 91 9892108169)
2. Mankind Pharma Ltd (Vote MP to+ 91 9892108169)
3. Pfizer Ltd (Vote PL to+ 91 9892108169)
4. Abbott India Ltd (Vote LL to+ 91 9892108169)
Pharma CSR Organization of the Year 2011
1. Ranbaxy Ltd (Vote RL to+ 91 9892108169)
2. Wockhardt Foundation (Vote WF to+ 91 9892108169)
3. Zydus Cadila Ltd (Vote ZC to+ 91 9892108169)
4. Piramal Enterprises. (Vote PE to+ 91 9892108169)
Pharma Professional Of the Year 2011 ( No Voting)
1. Dr Kamal Sharma, MD, Lupin Ltd
2. Dr Ajit V Dangi, President & CEO, Danssen consulting
3. Mr Ranjit Shahani, Vice Chairman & MD, Novartis India Ltd.
Lifetime Achievement Award of 2011 ( No Voting)
1. J.B.Mody, Chairman J.B.Chemicals & Pharmaceuticals Ltd
2. Deepak Pahwa, Chairman, Pahwa Enterprises.
Brand of the Year 2011
1. Revital (Vote RE to+ 91 9892108169)
2. B-COLEN (Vote BC+ 91 9892108169)
3. Becosule (Vote BE to+ 91 9892108169)
4. Violin (Vote VO to+ 91 9892108169)
5. Corex . ((Vote CO to+ 91 9892108169)
Innovative R & D Company of the Year 2011
1. Bharat Biotech International Ltd. (Vote BBIL to+ 91 9892108169)
2. Glenmark Pharmaceuticals Ltd. (Vote GPL to+ 91 9892108169)
3. Zydus Cadila Ltd. (Vote ZC to+ 91 9892108169)
4. Cipla Ltd. (Vote CL to+ 91 9892108169)
India's Most Admire Surgeon Of the Year 2011 ( No Voting)
India's Fastest growing Pharmacy Retail chain 2011
1.Dr Devi Shetty, Chairman,Narayana Hrudayalaya.
1. Trust Chemist & Druggist Ltd. ((Vote TC to+ 91 9892108169)
2. Hetero Pharmacy Ltd. ((Vote HP to+ 91 9892108169)
3. Apollo Pharmacy. ((Vote AP to+ 91 9892108169)
4. Religare Pharmacy. ((Vote RP to+ 91 9892108169)
1. Dr Surinder Singh – Drug Controller General of India.
1. Synergy Dignostic Pvt Ltd. ((Vote SD to+ 91 9892108169)
2. El-Shaddai Biologicals Ltd. ((Vote EB to+ 91 9892108169)
3. VHB Lifesciences Ltd. ((Vote VL to+ 91 9892108169)
1. GSK Ltd ((Vote GSK to+ 91 9892108169)
2. Novartis India Ltd. (Vote NIL to+ 91 9892108169)
3. Abbott India Ltd. (Vote ALI to+ 91 9892108169)
4. Glenmark Ltd. (Vote GL to+ 91 9892108169)
5. Microlabs Ltd.(Vote ML to+ 91 9892108169)
1. Bliss GVS Pharma ((Vote BGV to+ 91 9892108169)
2. Novartis India Ltd. (Vote NL to+ 91 9892108169)
3. Abbott India Ltd. (Vote AI to+ 91 9892108169)
4. Glenmark Ltd. (Vote GL to+ 91 9892108169)
5. Galpha Labs Ltd. (Vote GAL to+ 91 9892108169)
1. Aanjaneya Lifecare Limited ((Vote ALL to+ 91 9892108169)
2. Bliss GVS Pharma . (Vote BGPL to+ 91 9892108169)
3. Lincoln Pharmaceuticals Ltd. (Vote LPL to+ 91 9892108169)
4. Venus Remedies Ltd. (Vote VRL to+ 91 9892108169)
5. Duraent Bilogicals ltd. (Vote DBL to+ 91 9892108169)
1. Hetero Drugs Ltd ((Vote HD to+ 91 9892108169)
2. Aarti Drugs Ltd . (Vote AD to+ 91 9892108169)
3. Parabolic Drugs Ltd. (Vote PDL to+ 91 9892108169)
4. Aurobindo Pharma Ltd . (Vote APL to+ 91 9892108169)
1. Ipca Labs Ltd. ((Vote IL to+ 91 9892108169)
2. Shreya Life-Sciences Ltd (Vote SLS to+ 91 9892108169)
3. Genom Biotech Ltd . (Vote GB to+ 91 9892108169)
4. Glenmark Ltd. (Vote GL to+ 91 9892108169)
5. Sun Pharmaceuticals Industries Ltd.(Vote SPIL to+ 91 9892108169)
1. Dr. Rashmi Barbhaiya, MD & CEO, Advinus Therapeutics Pvt Ltd,
1. Abbott India Ltd (Vote ABBT to+ 91 9892108169)
2. Pfizer India Ltd . (Vote PIL to+ 91 9892108169)
3. Gsk Ltd (Vote GSK to+ 91 9892108169)
4. Sanofi Aventis. (Vote SAL to+ 91 9892108169)
1. Fortis Healthcare Ltd. (Vote FH to+ 91 9892108169)
2. Appolo Healthcare Ltd . (Vote AHL to+ 91 9892108169)
3. Max Healthcare Ltd (Vote MAX to+ 91 9892108169)
4. Wockhardt Hospitals . (Vote WH to+ 91 9892108169)
1. Samarth Pharma Ltd. (Vote SPL to+ 91 9892108169)
2. Indegene Lifesystems Pvt. Ltd (Vote ILP to+ 91 9892108169)
3. Serum Institute of India (Vote SIP to+ 91 9892108169)
4. Avesthagen Limited (Vote AVS to+ 91 9892108169)
5. Adroit Biomed Limited ( Vote ADR to to+ 91 9892108169)
Transformational Pharma Leader of the Year 2011 ( No Voting)
Excellence Innovators in Blood and Biological Products of the Year 2011
India's Most Admired Pharma Company 2011
India's Most Watched Company of the Year 2011
Emerging Company of the Year 2011
India's Most Admired Company in Bulk drugs 2011
India's Most Admired Company in Exports 2011
Research Scientist of the Year 2011
Multinational Company of The Year 2011
India's Most Admired Hospital Chain 2011.
Biotech Research Company of The Year 2011.
India's Most technically & scientifically advanced Pharmaceutical Manufacturing unit of the year
2011
1. Aanjaneya Lifecare Ltd ( No Voting)
9 10
?
?
nominations@pharmasummit.in

8. AWARDS AWARDS
Originally launched in 1999 as the Pharma Business & Technology Excellence Awards, these were first produced by the
PHARMA BUSINESS & TECHNOLOGY MAGAZINE as a means of honoring innovation in pharmaceutical marketing,
corporate governance and research and development & Lifetime Achievements category. Pharma Excellence Awards were
produced by PBT Awards in India and expanded to recognize global corporate citizenship and individual achievements.As
PBT Magazine wes discontinued, the task was taken up by the Management of Pharma Leaders Magazine. Over the Years,
the awards was re-evaluated and recast to focus more on scientific accomplishments in industry and academic
pharmaceutical research. The awards have been presented and at a sold-out gala award night. Since the institution of
Leadership Awards, over 200 industry executives and leading academic scientists from around the world have been
honoured. At a time when the pharma industry is facing some tough times—and the old way of doing things just won't work,
Our Expert Judges roll out the selection methodology to felicitate the top honours. An independent panel of prominent society
and industry leaders have been judging these awards. Winners have been selected via various processes & judging are based
on information provided by the nominees. Finalists are notified in advance - in writing. The final winners are announced at
the awards evening.
PHARMACEUTICAL
LEADERSHIP
2011
AWARDS CATEGORIES
1. Business Leader of the Year 2011
2. Business Woman of the Year 2011 ( Gen-Next Pharma Leader)
3. Dynamic Entreprenuer of the Year 2011
4. Pharma OTC Company of the Year 2011
5. India's Most Admired Nutrition & Neutraceuticals of the Year 2011
6. Company of the Year 2011
7. Pharma CSR Organisation of the Year 2011
8. Pharma Professional Of the Year 2011 ( No Voting)
9. Lifetime Achievement Award of 2011 ( No Voting)
10. Brand of the Year 2011
11. Innovative R & D Company of the Year 2011
12. India's Most Admire Surgeon Of the Year 2011 ( No Voting)
13. India's Fastest growing Pharmacy Retail chain 2011
14. Transformational Pharma Leader of the Year 2011 ( No Voting)
15. Excellence Innovators in Blood and Biological Products of the Year
2011
16. India's Most Admired Pharma Company 2011
17. India's Most Watched Company of the Year 2011
18. Emerging Company of the Year 2011
19. India's Most Admired Company in Bulk drugs 2011
20. India's Most Admired Company in Exports 2011
21. Research Scientist of the Year 2011
22. Multinational Company of The Year 2011
23. India's Most Admired Hospital Chain 2011.
24. Biotech Research Company of The Year 2011.
25. India's Most Technically & Scientifically Advanced Pharmaceutical
Manufacturing unit of the year 2011v
AN OVERVIEW
The Indian pharmaceutical industry in recent years has grown in stature from an industry that copies patent drugs and
manufactures them cheaply. It's now counted among the industries that are fueling India's economic growth and
holds vast potential. India-based pharmaceutical companies are also predicted to gain considerable market share in
the world by the end of this decade. The industry is estimated to have generated revenue worth US$13.1 billion in FY 2011.
India-based companies fulfill around 70 percent of the country's demand for bulk drugs, drug intermediates, pharmaceutical
formulations, chemicals, tablets, capsules, orals and injectibles. The Indian pharmaceutical industry is a “success story
providing employment for millions and ensuring that essential drugs at affordable prices are available to the vast population
of this sub-continent. Under these backdrops, Pharmaleaders will present the leading voices to debate at 4th Annual
Pharmaceutical Leadership Summit 2011 which has never been debated in any platform.
4Th Annual Pharmaceutical Leadership Summit & Awards 2011 is Asia's leading & prestigious Summit presented &
organized by india's leading Pharma Bi-Monthly PHARMALEADERS in association with Indo-American Chamber of
Commerce_IACC), delivering innovative, fully integrated and collaborative approaches to next generation Leadership
Issues. 4Th Annual Pharmaceutical Leadership Summit 2011 is a CEO / Senior Management level, interactive Summit
experience. The Summit speaker faculty are business and scientific pioneers from throughout Europe, US and Asia.
Arguably, It is Asia's most prestigious interactive forum where ideas, intelligence and relationships really make a difference.
The Summit attempts to tackles all the key strategic and collaborative issues facing the Pharmaceutical leadership transition
and new blend of leadership, both today and in the future over a succinct 1-day programme. The 2011 Pharmaceutical
Leadership Summit is where decision-makers from big pharma, early stage and mid stage vaccine biotechs, academia,
government and regulatory bodies and key industry stakeholders meet to learn and innovate for the future. More than 250
who's & Who's of the Industry will attend this Summit.
11 12

9. PARTNERS PARTNERS
Pharma Leaders is a bi-monthly publication from Pharmaleaders Academy. It is the leading pharma title in
print and digital versions serving the information needs of key executives from the world's leading
pharmaceutical companies. Pharma Leaderscovers important issues and trends shaping the future of the
pharma industry across Asia and rest of the world. Pharma Leaders offers Dedicated, reliable and accurate
coverage of the industry's progress and Incisive analysis to help its readers make informed decisions to
stay ahead of the competition.The magazine provides cutting-edge and futuristic content on the pharma
Established in 1968, the Indo-American Chamber of Commerce (IACC) is a non-government, industry led and
industry-managed organization, playing a proactive role in Indias development process and serves as a much
needed link between the business communities of India and the United States of America. IACC is the only
bilateral Chamber of Commerce in India, which is committed to development of Indo-US business and trade
relations. The major objective of IACC is to promote Indo-American business, trade and economic relations.
IACC promotes bilateral trade, investment and technology transfer, facilitates business collaborations, joint
ventures, marketing tie-ups and strategic alliances through a set of proactive business-oriented initiatives.
Organisation of Pharmaceutical Producers of India (OPPI) established in 1965, is a premier association of
research based international and large pharmaceutical companies in India and is also a scientific and
professional body. It caters to the needs of Research based Pharmaceutical Industry thereby creating and
sustaining an environment conducive to innovation and growth, simultaneously, facilitating industry and
stakeholders partnership through various advisory and consultative processes to achieve the Healthcare
objectives of the Nation.
Indian Pharmaceutical Association (IPA) is the premier professional association of pharmacists in India, with a
member base of over 10,000, spread across the length & breadth of the nation. IPA operates in India through 17 state
branches & more than 33 local branches. The members represent various facets of pharmaceutical profession viz.
Industry, regulatory, community pharmacy, hospital pharmacy & education. IPA is also actively associated in
managing several academic programmes. As member of Drug Technical Advisory Board, India, IPA is actively
involved in advising the government on matters of professional impotance. IPA is affiliated with international
pharma associations like FIP, FAPA, CPA, AAPS, AAiPS, IPSF & WHO, for carrying out various collaborative
professional activities which include organizing training programmes for professionals from industry, academics,
regulatory & practice, making representations to the authorities on matters of professional interest & working
towards constantly upgrading the standards of professional services offered by the pharmacists.
ndian Drug Manufacturers' Association (IDMA) was formed in 1961 to help Indian manufacturers and to
protect the interest of the Indian consumer. Membership of over 800 wholly-Indian large, medium and small
companies.Turnover of Indian pharma industry has grown exponentially from Rs.10 crore (about US 2million) in
1948 to about Rs. 1,00,000 crore (US $ 21 billion) today, a growth rate ofover15%.Members'Indian Market share –
about 75% in formulations and about 85% in bulk drugs.Exports of about Rs. 50,000crore (over US $ 10 billion)
last year growing at 22% average. Members' Export Record – about 65% of India's total drugs & pharma
exports.More than 150 factories are approved by US FDA, UK-MCA, Australia and South Africa Authorities and
many more are holding WHO-GMP certificates. India is ranked 3rd largest country in terms of production volume
All India Organisation of Chemists & Druggists - AIOCD has over about 5.5 Lac members from Retail Chemists
and Pharma Distributors/stockists. All these Members of AIOCD transact almost 95% of the overall pharma
business in India which is currently growing @12-to-13% on a year on year basis. AIOCD operates on PAN India
basis through all State and Union Territory level associations. AIOCD is the only true representative body of
pharma Trade in India. India being a vast country of diverse cultures, the problem of pharmaceuticals stockists and
retail chemists, also, varies from place to place. The tax structure being a state and federal subject, further
complicate the matter. The Pan India presence of AIOCD automatically evolves a role of a common link for them
between trade, pharma industry, government/regulators and community.
The dynamic growth of Indian Pharma Industry, a knowledge based industry, and the recommendations of four major
Pharma associations made the Ministry of Commerce & Industry to realize the need for separate export promotion
council. Accordingly, Pharmaceuticals Export Promotion Council (PHARMEXCIL) has been set up on 12.5.2004.
With its notification No.61 dt. 16.3.2005, Director General of Foreign Trade made Pharmexcil the sole agency to
issue RCMCs to all Pharma exporters. The activities of the Council are administered by Committee of Administration
consisting of representatives from major Pharma industries in India like J B Chemicals & Pharmaceuticals Limited,
Suven Life Sciences Limited, Dr. Reddy's Laboratories, Aurobindo Pharma, Luipin, Ranbaxy, Novarties, Avantis,
Ipca, Shasun, Sun Pharma, Zydus Cadila, Glowchem, Calyx etc., apart from Govt. officials from Central govt. and
Govt. of Andhra Pradesh. Administrative support to the Council is extended by very rich experienced personnel from
various fields like Govt. of India and Pharma industry.
The Bulk Drug Manufacturers Association (India) was formed in 1991 with Hyderabad as its Head Quarters. This is
a n a l l I n d i a b o d y r e p r e s e n t i n g mo s t o f t h e Bu l k Dr u g Ma n u f a c t u r e r s o f I n d i a .
The Association works for the consolidation of gains of the industry and serves as a coordinator and catalyst between
the government and the industry for the growth of the industry. Bulk Drug Industry is the backbone of the self-reliant
Pharmaceutical industry in India, playing a significant role in improving the health standards of the people.
Pharmaceutical manufacturers consisting of Formulations and Bulk Drugs and drug intermediates in large, medium
and small scale sectors in the country employ man power of above 45 lakhs both directly and indirectly.
The capital investment in the pharma industry is about Rs.35,000 crores. Today 90% of the domestic bulk drugs
requirement is met by the Indian industry, itself. The Bulk Drug industry contributed about Rs. 48,000 Crores worth
of exports, during the year 2010-2011 which is growing by over 15%-20% every year. Over 45% of the worlds bulk
drug requirement is met by India.
The Pharmaceutical Wholesalers" Association (Bombay), is an independent body of Pharmaceuticals & Allied
Products Wholesalers of Mumbai. It provides safety, security and prosperity to its members. (The area under PWA
jurisdiction is Colaba to Dahisar in Western Track & upto Mulund in Central; in Harbour line the area is upto
Mankhurd). P.W.A plays the role of facilitator and meet the needs of our members, to know their aspirations and
respond creatively. To act as an interface between retail chemists and Industry. Our long-term success was; due to
transparency, commitment, working together effectively and willingness to be receptive to new ideas and learn
continuously. We shall formulate and amend our norms, which will ensure safety, security and prosperity of our
members. The inspirational spirit behind our work is our famous motto. “None of us is as strong as all of us”
Stage Craft India provide Audio-Video systems, stage hire and lighting for all types of events including –
Corporate events Theme parties Sports events Fashion shows Movie premiers Music launches Award nites
Brand launches Promotions Live concerts Televised shows We have over 20 years of experience in sound
reinforcement, sound systems, stage hire, lighting hire and design. We pride ourselves on our high levels of service,
experienced sound engineers and reliability.Our clients include event organizers, promoters, theatre companies,
companies, corporations, local authorities, festival organizers and artists. Stage Craft is dedicated to negotiating the
best possible terms for our clients. We can help you select the perfect mix of features and services within your
budgets
20 years ago Mr. Prashant & Mrs. Bijal Kalbag a husband & wife team launched Creative Awards & Rewards a
company set up to provide 100% personalised solutions to meet the creative demands of its customers. With constant
innovation a “Never Say No” attitude & by adding diverse materials into their existing range, the company has
growth steadily into the established. The Company provides a bouquet of perfectly crafted products made of Metal,
Steel, Crystal/Glass, Wood, Acrylic, Fiberglass, Soft PVC, Leather and Ceramic to suit every budget.Besides,
Trophies, Presentation Plaques and Cups, Creative Awards also offers a range of Corporate and Promotional Gift
items like Crystal Candle Holders/Paperweights/Min. Clocks/Ganeshas/Vases/ Glasses/ Bowls, Time Pieces – Wrist
Watches/ Wall & Desktop Clocks, Stationery Items in Wood and Metal like Photo frames /Pens and Pen holders,
Calendars, 1. Pen/Mobile & Visiting card holders, Miscellaneous Items like Coasters, Ceramic Mugs and Plates,
Bar Sets…… and promotional and gift items made of Stainless Steel, Leather, Soft PVC, Lenticular Products as per
y o u r d e s i g n a n d s p e c i f i c a t i o n s .
The entire gamut of operations-right from computerized designing, crystal, metal casting, wooden, acrylic, painting
and packaging department are all available under one roof to ensure quality and timely deliveries. So, to help you
achieve the impact you seek, this mailer has been issued to especially inform you that we have come up with a new
range of products in the above mentioned categories. Just give us a call & we will either send our Sales
Representative across or will send to you a Video Mail of this new range. Alternatively, you could send us online
With a zest for continuous improvement, over the decades Print & Pack has provided the best printing applications
and a wide range of services. with state–of-the–art technology and infrastructure. Print & Pack is hallmarked for
being a one-stop solution for all printing needs for individuals, businesses and MNCs. We aim at optimizing brand
representation of our clients with quality enhancement, time management and cost-effectiveness. As Print & Pack
continuous to progress with technology, we still emphasize on old fashioned values like quality and loyalty. This has
enabled us. to successfully convert the trust of every client into a lifetime relationship through unparalleled printing
quality and services.
13 14

10. PARTNERS
Established in 1984, General Data Pvt Ltd provides customized solutions on demand. We provide services ranging
from portals to full fledged corporate web solutions; from customized reporting tools to complete desktop and
information sharing systems. Our unique process of problem analysis provides us a very effective efficient solution
for maximum customer satisfaction. GDPL´s group Companies have agreement with various MNC´s and
International Fortune 500 companies viz. Kodak Ltd. and Dupont which speaks about our integrity and quality
consciousness. A new entity was founded in 1958 with the establishing of Gorakhram haribux - the first company to
introduce car airconditioners in India. From then onwards, for over a span of 45 years, Our activities were growth-oriented.
We diversified into Refrigeration system & Gases. Industrial Transformers, Conversion of jumbo Rolls of
Photographic Color Paper and Graphic Art Film, Document Imaging, Sport & Leisure equipment and leasing of real
Estate. Our group annual turnover is over Rs. 70 million with over 100 employees. Our Head Office is located at
Nariman Point, Mumbai. Our Plants are located at Silvassa and Pune. We have Branches and Representatives in most
major cities in India. The group has long-standing liaison and collaborations with foreign companies. International
trade has made us quality conscious. While our cornerstone has always been co-operation, Mutual prosperity, solid
With a zest for continuous improvement, over the decades Adroit Digital Ideas has provided the best printing
applications and a wide range of services. with state–of-the–art technology and infrastructure. Adroit is hallmarked
for being a one-stop solution for all printing needs for individuals, businesses and MNCs. We aim at optimizing brand
representation of our clients with quality enhancement, time management and cost-effectiveness. As Adroit
continuous to progress with technology, we still emphasize on old fashioned values like quality and loyalty. This has
enabled us. to successfully convert the trust of every client into a lifetime relationship through unparalleled printing
quality and services.
Oxygen Infotainment is the one stop destination for the total infotainment solutions. As we believe "No matter how
creative and innovative your firm is the only software genuinely worth having is the customer relationship, based on
mutual advantage and trust. Individual, differentiable customer relationships will be the ultimate software of
businesses in the 1:1 future. All your products are ephemeral. Only your customers are real."
CARE WORLD TV, Asia's only Satellite healthcare TV Channel, emerged as the need of the hour by fulfilling a
vacant niche, has successfully completed 2 years of disseminating health related information to the masses thus
bridging the gap between the functionary and the beneficiary. Keeping in tune with the Boom in the healthcare
Industry with constant changes, in trends , development , research , we have now re - launched 7 STAR CARE in a
new Avatar as CARE WORLD a much improved version with an International & Contemporary feel with slick
Presentation , state of the art Production values and exclusive Content. We offer various innovations in customized &
interactive programming thus offering a range of formats for Health Industry to communicate their invaluable
messages to a widespread and highly focused, and very responsive audience.CARE WORLD's prime focus and
objective is to integrate health & fitness in its total sense encompassing Mind, Body, Beauty And Soul. With CARE
WORLD we will continue our commitment & quest in serving the Masses and the Health industry and fulfill an ever
expanding demand for health care information and services.
PR Newswire ( www.prnewswire.com
) is the premier global provider of multimedia platforms that enable marketers,
corporate communicators, sustainability officers, public affairs and investor relations officers to leverage content to
engage with all their key audiences. Having pioneered the commercial news distribution industry 57 years ago, PR
Newswire today provides end-to-end solutions to produce, optimize and target content – from rich media to online
video to multimedia – and then distribute content and measure results across traditional, digital, mobile and social
channels. Combining the world's largest multi-channel, multi-cultural content distribution and optimization network
with comprehensive workflow tools and platforms, PR Newswire enables the world's enterprises to engage
opportunity everywhere it exists. PR Newswire serves tens of thousands of clients from offices in the Americas,
Europe, Middle East, Africa and the Asia-Pacific region, and is a UBM plc company.
Global Advertisers brings the talents of over 20 marketing professionals together to create the kind of strategic
thinking that sells. You can't move a product until you move a person and the advertising we generate has proven
extremely effective in doing just that. We create concept that stands out from the crowd, conveys a message that hits
home and sells your product or service. So contact us today and get the unstoppable services & unmatched packages.
Our talented creative people are all experts in their field and we always match the right skills to the right job.
15 16

11. VENUE
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Driver's For Growth -
AN ENDURING LANDMARK IN INDIA'S COMMERCIAL CAPITAL InterContinental
The LaLiT Mumbai hotel represents understated luxury, a peaceful oasis from the
frenetic city outside. Being at the nerve centre of the fastest developing business
hub, Andheri, InterContinental The LaLiT Mumbai has easy access to other
business districts of the financial capital of the country. InterContinental The LaLiT
welcomes all its guests to the best airport hotel in the city, an ideal abode for the
global traveler.InterContinental The LaLiT Mumbai projects a magnificent
architectural façade with its 368 options of hotel accommodation Mumbai With
Asia's largest Atrium Lobby, a lavish 7 story high feature welcoming the guests,
this five star luxury hotels Mumbai is a marvelous combination of grandeur and
sophistication.
Contact Details : Agatha Gomes,Sales Executive - Catering & Events
InterContinental The LaLiT Mumbai Sahar Airport Road, Andheri East,
Mumbai. Mobile : +91 9004653639
Telephone Direct: +91-22- 30673375, Facsimile Direct: +91-22-
66998888, agomes@thelalit.com , www.thelalit.com
REGISTRATION
Gen-Next Indian Pharma Leaders
Billionaire Minds
-Re-Inventing Drivers for Growth-Saturday,
10th Dec,2011,Hotel Lalit Intercontinental, Airport Road,Mumbai,India
3RD ANNUAL PHARMACEUTICAL LEADERSHIP SUMMIT & AWARDS 2011
Registration Application
Registration Informations:
Per Delegate Fees: INR RS 10,000 + 10.30 SERVICE TAX
We are pleased to nominate the following participant(s) for the Summit:
Sr : Name : Designation:
Email id :
1.______________________________ _______________________ _______________
2.______________________________ _______________________ _______________
3.______________________________ _______________________ _______________
The DD / Cheque No. ________________ for Rs. ________________ towards the delegate fee drawn in
favour of “NOBLE SERVICES”, payable at Mumbai is enclosed.
Name:________________________________________________Designation :____________
Company:_____________________________________ IACC Membership No:
Address:_______________________________________________________________________________
Telephone:__________________________Fax:_________________________Mobile:_________________
Email:_________________________________________Website:_________________________________
Terms & Conditions
The Delegate Fee is inclusive of the Service Tax and Education Cess @ 10.30%
ØPre-Registration and Pre-Payment is a must
ØA 10% discount for 3 or more delegates
ØDelegate fee non-refundable but change in nomination accepted
ØPayment can made via wire Transfer through Online Payments
Ø10% Discount to OPPI/IDMA/BDMA/IPA/PHARMEXCIL Members
Ø50% Discount to Indo-American Chamber of Commerce ( IACC) – Co-Organiser
Summit Secretariat & Registration Desk.
4th Annual Pharmaceutical Leadership Summit 2011, Summit Secretariat. Noble Services, Accord Group of Companies,
Dimple Arcade, 3rd floor, 314, Asha Nagar, Landmark – Behind Sai Dham Mandir. Kandivali east, Mumbai – 400101. Mr.
Sohail Shaikh - 08888117599 , Mr. Mohsin Darvesh - 0810 8120 436 , Email :
pharmasummit2011@webnoble.co.in
17 18 www.pharmasummit.in

12. 19
THE GROUP
Network 7 Media Group Media Outfit is a result of emergence of an extreme thought process in the form
of some of the biggest & exclusive media properties that arose due to the frustration & disappointment of
the present status-quo of the society in existence in the form of a careless & extremely insensitive
administration of a large set-up. Network 7 Group has continuously strived to expose the misdeeds of
the corrupt administrative fabrics or poor legislation or failure of a large entity in corporate
governanance. Distinctively standing out of other media initiatives, Network 7 group has been in the
forefront of championing the cause of good governance & fair, unbiased & independent reporting in
national & international fields. Driven by the objective to address & deliberate some of the burning
issues, sometimes neglected causes, Network 7 Media Group Media Outfit is pioneering the concept of
introducing a fierce democratic process in the form a mass resistance in bringing into the forefront of
issues that matter most in the form of digital, printed, published, conclaves, summits & even in blogs &
letters shoot out to the authoritative. Headquartered in Mumbai, Network 7 Group Media Outfit is
backed & operated by some of the biggest think-tanks of the contemporary society whose ideas &
actions are reflected in the form of editorials & exclusive news findings. Network 7 Group Media is
present in the form of digital media production, publications, high-profile international events &
healthcare communications. Some of the flagship products of the Group are as follows .
INDIAN AFFAIRS: www.indianaffairs.in
( Business Magazine quarterly)
The timing of launching Indian Affairs Magazine ( www.indianaffairs.in ), "India's first ever Pink
Magazine on political, business, socio-economic & current affairs from Indian Affairs Pvt Ltd, a
flagship Company of Network 7 Group is driven by an objective to bring out ground-breaking true
stories to the Indian masses without any interference from lobbyists & corporate houses. The Pink
Magazine is present in the form of a digital & print editions. The editorial board of Indian Affairs is
composed of journalists in different sections of the society with wide-ranging areas of expertise in
business, political, investigative, international & cultural journalism. Their primary responsibility is
to write Indian Affairs's editorials, which represent the voice of the board, its editor and the publisher.
www.pharmaleaders.co.in
PHARMA LEADERS : ( India's Most Analytical Bi-Monthly
Magazine on Healthcare)
Pharmaleaders,the flagship media outfit of Network 7 Group which also publishes India's leading
current affairs pink Magazine "INDIAN AFFAIRS" ( www.indianaffairs.in ) India's leading &
arguably one of the best news Magazine in Asia & has over the last one year emerged out as one of the
most credible voice with Independent & unbiased reporting in the healthcare industry. Known for its
accurate reporting &
direct uncomfortable questions to the leading voices of the Healthcare Industry, the objective of the
Magazine is to present facts & bring to the limelight the real face of the organization's interface to its
internal & external stakeholders. In line with, Corporate ethics & fair governance. Present in the form
of Digital & Printed publications, Pharmaleaders is the voice of the healthcare Industry in India. Today
Pharmaleaders is a leading title in Healthcare Media both in the form of Digital & Printed Publications.
Pharmanewsprwire : is India's Only Pharma Press Distribution Newswire Agency that address the
needs of disseminating informations to the targeted audiences. Pharmanewsprwire is a vibrant platform
of knowledge sharing & dissemination of informations on the latest trends, news & analysis of the
entire gamut of the healthcare industry.Behind the infrastructure of pharmaprnewswire.comand its
powerful database of thousands of Pharmanewsprwire is a dedicated team of experts in all aspects of
media communications.Our people are highly experienced journalists, editors and publishers, with
high-profile media careers on leading newspapers and magazines around the country.We keep our
finger on the pulse, keeping up to date with movements across the industry so our database is as current
as possible.
THE GROUP
20

13. 2011: A Springboard Year
T
he Summit is your best opportunity to acquire knowledge of lessons learned, gain information regarding current practice,
promising opportunities, impending influences, and insights into developments that become expectations of our
organizations. For whatever time you may devote to participation with us, PHARMA LEADERS BOARD is determined to
provide a great conference at a time when it is greatly needed. Your Summit experience will be one of knowledge acquisition, staff
development, marketplace awareness and exposure to those trends and issues most relevant to educational technologies and services.
The core of what we are about is support of the institutions we represent, in particular Healthcare. Your Board and I look forward to
effectively serving you, helping you to address and resolve barriers encountered in achieving excellence in addressing some of the
Biggest Challenges that we all are facing!
It is always easier to do ten-year forecasting than one-year forecasting, but it is especially true now. Stuck in 2011, it seems impossibly
difficult to forecast the future because the present is so messy. Now however—in the midst of the mess—is exactly the time when ten-year
forecasting can be most valuable. 2011 is authentically frightening, but it also has great potential to be a springboard year. Volatility,
uncertainty, complexity, and ambiguity are likely to get worse in 2011. Many people are already choking on uncertainty most of the
time—especially people on the down side of the rich/poor gap. Some leaders are still expecting a return to predictability. As someone
who has been doing ten-year forecasting for more than thirty-five years, let me be very clear about my view: if you are not confused by
2011 and the future we are facing, you are not paying attention. The future cannot help you unless you are willing to listen through the
confusion. You cannot learn from the future if you are overwhelmed by the present or stuck in the past. I believe that the next decade,
beginning in 2011, will be characterized by both danger and opportunity. Leaders will be buffeted, but they need not allow themselves to
be depressed or immobilized. Leaders must do more than just respond to crises, though respond they must. Some of today's leaders have
already turned nasty out of frustration, with considerable cause. Still, leaders can be positive change agents in the midst of chaos. Some
things can get better, even as other things get worse. Organizations need a readiness discipline that assumes uncertainty, but achieves
success nonetheless. Ten-year forecasters can help leaders gain perspective by looking long. One of the reasons for the current
economic crisis is that short-term betting dominated long-term thought in many marketplaces. Foresight can provoke insight, even if
you don't agree with the forecast. A discipline of thinking from foresight to insight to action leads—almost always—to better decisions
in the present. Problem-solvers beware: even though solvable problems will still abound in the next decade, top leaders will deal mostly
with dilemmas where there is no solution—but where you have to make decisions anyway. The best leaders will thrive in the space
between judgment too soon (the classic mistake of the problem solver) and deciding too late (the classic mistake of the academic).
Leaders will not be able to control or problem solve through volatility, uncertainty, complexity, and ambiguity. Leaders must learn how
to see through the mess with a global futures perspective, to sense patterns of change. That is what ten-year forecasting is all about. 2019
is much more clear than 2011, if only leaders take the time to look long. We know, for example, that 2019 will be a world with sensors
and wireless everywhere—even in the developing world. We know that Facebook generation will be in leadership positions by 2019,
though their ways of leading are only just becoming apparent. My assessment is that 2011 is the beginning of a threshold decade: our
natural systems will reach tipping points of extreme challenge and some of those systems may break. Our business, organizational, and
social systems will be stretched too, some of them to the breaking point. We also know that we will be even more connected in 2019 than
we are today. I believe that the more connected we are, the safer we are, the more free we are, and the more powerful we are—if we
realize the benefits of connectivity. We are more connected than ever before and we are—almost everyone is—globally connected. But
there are downsides: the more connected we are, the more dangerous it can be, as our current economic crisis is revealing. Leaders must
make the links, draw the connections, organize people for action—but protect against the dangers inherent in super-connectivity.
Leaders must engage with chaotic global future forces and figure out how to make a better future. Certainly, the focus for many people in
2011 must be on holding the fort and surviving. But in every organization, there should be at least a small band of leaders with license to
think about and plan for the future. 2011 is threatening, but it is also an ideal time to be looking ahead—beyond the current crises. If we
stew ourselves in 2011, we'll never get to 2019. Those organizations that do nothing but hunker down in this crisis will be way behind
when things start getting better. Leaders can make the future, but they won't make it all at once and they can't make it alone. 2011 can be a
springboard year, if leaders use foresight to spark their own insight and inform their own action.
21
GENERATION NEXT INDIA PHARMA LEADERS
- Reinventing Driver's For Growth -
WHERE ARE WE?
22 22
NOTES
Your Take Away From the Summit

14. 23 22
NOTES
Your Take Away From the Summit
24 22
NOTES
Your Take Away From the Summit